Trials / Completed
CompletedNCT00404131
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Subjects With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to compare the effectiveness and safety of INS365 Ophthalmic Solution with placebo when applied topically in subjects with dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diquafosol tetrasodium (INS365) Ophthalmic Solution |
Timeline
- Start date
- 2001-03-01
- Primary completion
- 2001-12-01
- Completion
- 2001-12-01
- First posted
- 2006-11-27
- Last updated
- 2016-11-29
Source: ClinicalTrials.gov record NCT00404131. Inclusion in this directory is not an endorsement.